Hanx Biopharmaceuticals partners with Ditu Zhiyuan on AI-driven cancer drug researchPUBT·Nov 16, 2026 at 10:25 AM03378-4.26%
Algorithmic Alchemy: Two Hong Kong Stocks Betting on Materials Science 2.0Global Report·Oct 24, 2026 at 09:14 AM03378-4.26%003650.00%
Weekly Recap | HANXBIO-B -5.33%, strategic tie-up with XtalPiWeekly Review·Sep 26, 2026 at 05:28 AM03378-4.26%
HANXBIO-B Reaches Cooperation on AI Applications in Antibody Design and Drug R&D With XTALPIAASTOCKS News·Sep 22, 2026 at 02:15 AM03378-4.26%
Hanx Biopharmaceuticals Taps XtalPi’s AI Platform to Accelerate Drug R&DTip Ranks·Sep 21, 2026 at 11:10 AM03378-4.26%
Reshaping the Fringes: OSL's Crypto Pivot and Boardware's Bold AI BetGlobal Report·Sep 15, 2026 at 11:33 AM03378-4.26%02651+6.11%
HK Niche Equities Signal Stabilization Amid Diverging Sector PathsGlobal Report·Sep 15, 2026 at 09:18 AM018730.00%03378-4.26%
Mixed Micro-Cycle Signals Emerge Across Selected Hong Kong EquitiesGlobal Report·Sep 15, 2026 at 07:01 AM018730.00%03378-4.26%
Hansight Biotech Plans Placement Of Up To 13.4 Million WarrantsCoinLive·Sep 13, 2026 at 11:10 AM03378-4.26%